Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation

PURPOSE: To compare the risk of transient vision loss (TVL) probably attributable to a severe intraocular pressure spike after intravitreal aflibercept application using the novel prefilled syringe (PFS) vs. the established vial system (VS). METHODS: Datasets of the intravitreal injection service of...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaas, Julian E., Bui, Vinh, Maierhofer, Niklas, Schworm, Benedikt, Maier, Mathias, Priglinger, Siegfried G., Siedlecki, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634539/
https://www.ncbi.nlm.nih.gov/pubmed/37954554
http://dx.doi.org/10.3389/fmed.2023.1295633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634539/
https://www.ncbi.nlm.nih.gov/pubmed/37954554
http://dx.doi.org/10.3389/fmed.2023.1295633

Ejemplares similares